TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1)
塔夫茨临床与翻译科学研究所 (UL1)
基本信息
- 批准号:8365114
- 负责人:
- 金额:$ 205.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject represents an estimate of the percentage of the CTSA funding that is
being utilized for a broad area of research (AIDS research, pediatric research, or
clinical trials). The Total Cost listed is only an estimate of the amount of CTSA
infrastructure going towards this area of research, not direct funding provided by
the NCRR grant to the subproject or subproject staff.
Leveraging Tufts University's excellent resources, traditions of multidisciplinary collaboration, generation of novel research methods, and academic innovation, including the first MS/PhD Clinical Research (CR) Program in a graduate school of biomedical sciences, we will establish the Tufts Clinical and Translational Science Institute (CTSI). This will unite eight Tufts Schools (Arts & Sciences, Citizenship and Public Service, Dental Medicine, Engineering, Graduate Biomedical Sciences, Medicine, Nutrition, and Veterinary Medicine), eight affiliated hospitals, the Tufts Center for the Study of Drug Development, the USDA Human Nutrition Research Center on Aging at Tufts, and the Tufts-New England Medical Center (Tufts-NEMC) Institute for Clinical Research and Health Policy Studies. This will: 1) Create a new home for clinical and translational clinical research (CTR), a cross-University, cross-affiliate Tufts CTSI, headed by an international leader in CTR who will report to the University Provost; 2) Create eight research resource Components suggested by the CTSA RFA, plus four based on special Tufts strengths; 3) Enhance and expand the "CR Portal" at Tufts- NEMC into a Tufts-wide "CTSI Portal" that provides coordinated and mentored University- and affiliate-wide access to CTSI Components and other resources; 4) Create activities, processes, and new information systems that will support and promote collaborative cross-disciplinary full-spectrum translational research; and 5) Enhance our MS/PhD CR Program by a) adding to the existing four Concentrations (Clinical Investigation, Epidemiology/Biostatistics, Health Services and Outcomes Research, and Medical Informatics), Concentrations in Bench-to-Bedside Translational Research and in Evidence-Based Medicine; b) developing distance learning to extend the Program to fellows, K12 scholars, and other faculty at Tufts affiliates across Massachusetts; c) creating the joint Pfizer Tufts Career Development Awards; d) preparing predoctoral tracks for Tufts MD, DMD, and DVM students to also get a CR MS or PhD; e) developing joint tracks for students to get an MS in Nutrition or in Biomedical Engineering with a PhD in CR; and f) developing a program to generate interest in CTR among students from underrepresented minority groups. In all aspects of training, research support, and organizational development, the Tufts CTSI will support and instill the culture of cooperative interdisciplinary research, a home without walls, for CTR Tufts-wide.
该子项目是对CTSA供资的百分比的估计,
用于广泛的研究领域(艾滋病研究,儿科研究,或
临床试验)。 列出的总成本仅为CTSA金额的估算
基础设施走向这一领域的研究,而不是直接提供资金,
向子项目或子项目工作人员提供NCRR补助金。
利用塔夫茨大学的优秀资源,多学科合作的传统,新的研究方法的产生和学术创新,包括生物医学科学研究生院的第一个MS/PhD临床研究(CR)计划,我们将建立塔夫茨临床和转化科学研究所(CTSI)。这将联合八所塔夫茨学校(艺术与科学,公民和公共服务,牙科医学,工程,研究生生物医学科学,医学,营养学和兽医学),八家附属医院,塔夫茨药物开发研究中心,美国农业部塔夫茨人类营养研究中心,塔夫茨-新英格兰医学中心(Tufts-NEMC)临床研究和卫生政策研究所。这将:1)创建一个新的家临床和转化临床研究(CTR),一个跨大学,跨附属塔夫茨CTSI,由CTR的国际领导者领导,他将向大学教务长报告; 2)创建CTSA RFA建议的八个研究资源组件,加上四个基于特殊塔夫茨优势; 3)加强和扩大塔夫茨- NEMC的“CR门户网站”成为塔夫茨范围内的“CTSI门户网站”,提供协调和指导的大学和附属机构范围内访问CTSI组件和其他资源; 4)创建活动,流程和新的信息系统,以支持和促进跨学科的全方位翻译研究;和5)通过a)增加现有的四个浓度来加强我们的MS/PhD CR计划(临床调查,流行病学/生物统计学,卫生服务和成果研究,以及医疗信息学),集中在台床转化研究和循证医学; B)发展远程学习,将该计划扩展到马萨诸塞州的塔夫茨附属机构的研究员,K12学者和其他教师; c)创建联合辉瑞塔夫茨职业发展奖; d)为塔夫茨MD,DMD和DVM学生准备博士预科课程,以获得CR MS或博士学位; e)为学生开发联合轨道,以获得营养学硕士学位或生物医学工程与CR博士学位;和f)开发一个程序,以产生来自代表性不足的少数群体的学生对CTR的兴趣。在培训,研究支持和组织发展的各个方面,塔夫茨CTSI将支持和灌输跨学科合作研究的文化,一个没有围墙的家,为CTR塔夫茨全。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harry P. Selker其他文献
Is primary angioplasty for some as good as primary angioplasty for all?
- DOI:
10.1046/j.1525-1497.2002.11232.x - 发表时间:
2002-12-01 - 期刊:
- 影响因子:4.200
- 作者:
David M. Kent;Christopher H. Schmid;Joseph Lau;Harry P. Selker - 通讯作者:
Harry P. Selker
Academic General Internal Medicine: A Mission for the Future
- DOI:
10.1007/s11606-013-2334-3 - 发表时间:
2013-01-16 - 期刊:
- 影响因子:4.200
- 作者:
Katrina Armstrong;Nancy L. Keating;Michael Landry;Bradley H. Crotty;Russell S. Phillips;Harry P. Selker - 通讯作者:
Harry P. Selker
Physician electrocardiogram reading in the emergency department—Accuracy and effect on triage decisions
- DOI:
10.1007/bf02599153 - 发表时间:
1992-07-01 - 期刊:
- 影响因子:4.200
- 作者:
Robert L. Jayes;Greg C. Larsen;Joni R. Beshansky;Ralph B. D’Agostino;Harry P. Selker - 通讯作者:
Harry P. Selker
Extending the electrocardiogram's role to address patient safety and quality improvement practices
- DOI:
10.1016/j.jelectrocard.2005.06.046 - 发表时间:
2005-10-01 - 期刊:
- 影响因子:
- 作者:
Manlik Kwong;Denise Hartnett Daudelin;Harry P. Selker;Joni R. Beshansky - 通讯作者:
Joni R. Beshansky
Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials
- DOI:
10.1016/j.ahj.2017.02.028 - 发表时间:
2017-06-01 - 期刊:
- 影响因子:
- 作者:
Harry P. Selker;James E. Udelson;Robin Ruthazer;Ralph B. D'Agostino;Melissa Nichols;Ori Ben-Yehuda;Ingo Eitel;Christopher B. Granger;Paul Jenkins;Akiko Maehara;Manesh R. Patel;E. Magnus Ohman;Holger Thiele;Gregg W. Stone - 通讯作者:
Gregg W. Stone
Harry P. Selker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harry P. Selker', 18)}}的其他基金
Tufts Clinical and Translational Science Institute (Clinical Trial Design Labs Supplement)
塔夫茨临床和转化科学研究所(临床试验设计实验室补充材料)
- 批准号:
10844980 - 财政年份:2023
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Science Institute
塔夫茨临床与转化科学研究所
- 批准号:
10622002 - 财政年份:2023
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Science Institute
塔夫茨临床与转化科学研究所
- 批准号:
9816143 - 财政年份:2018
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Science Institute
塔夫茨临床与转化科学研究所
- 批准号:
10159334 - 财政年份:2018
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Science Institute
塔夫茨临床与转化科学研究所
- 批准号:
10412102 - 财政年份:2018
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Science Institute (Pilot Supplement)
塔夫茨临床与转化科学研究所(试点增刊)
- 批准号:
10260036 - 财政年份:2018
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Science Institute (N3C Supplement)
塔夫茨临床与转化科学研究所(N3C 增刊)
- 批准号:
10172199 - 财政年份:2018
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Research Institute
塔夫茨临床与转化研究所
- 批准号:
8743320 - 财政年份:2013
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Research Institute
塔夫茨临床与转化研究所
- 批准号:
9278321 - 财政年份:2013
- 资助金额:
$ 205.38万 - 项目类别:
Tufts Clinical and Translational Research Institute
塔夫茨临床与转化研究所
- 批准号:
8720923 - 财政年份:2013
- 资助金额:
$ 205.38万 - 项目类别:
相似海外基金
Research on measures to activate science communication at research institutes such as domestic universities
国内大学等科研机构激活科学传播的措施研究
- 批准号:
21K02927 - 财政年份:2021
- 资助金额:
$ 205.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NSF Graduate Institutes for Science Communication and Public Engagement
美国国家科学基金会科学传播和公众参与研究生院
- 批准号:
1753667 - 财政年份:2017
- 资助金额:
$ 205.38万 - 项目类别:
Standard Grant
Canadian Institutes of Health Research - Health Research Communications Award (2012-2013) Master of Science in Biomedical Communications
加拿大卫生研究院 - 健康研究传播奖(2012-2013)生物医学传播理学硕士
- 批准号:
285268 - 财政年份:2013
- 资助金额:
$ 205.38万 - 项目类别:
Studentship Programs
Science Advanced through Virtual Institutes (SAVI): Virtual Institute for Responsible Innovation
通过虚拟研究所 (SAVI) 促进科学进步:负责任创新虚拟研究所
- 批准号:
1257246 - 财政年份:2013
- 资助金额:
$ 205.38万 - 项目类别:
Standard Grant
The Role of Software and Software Institutes in Computational Science Over Time
随着时间的推移,软件和软件学院在计算科学中的作用
- 批准号:
1256100 - 财政年份:2012
- 资助金额:
$ 205.38万 - 项目类别:
Standard Grant
US/India Workshop on Virtual Institutes for Computational and Data-Enabled Science & Engineering
美国/印度计算和数据科学虚拟研究所研讨会
- 批准号:
1210266 - 财政年份:2012
- 资助金额:
$ 205.38万 - 项目类别:
Standard Grant
Canadian Institutes of Health Science-Science to Business (S2B) program
加拿大健康科学研究所-科学到商业 (S2B) 项目
- 批准号:
256525 - 财政年份:2012
- 资助金额:
$ 205.38万 - 项目类别:
Studentship Programs
Canadian Institutes of Health Research - Science to Business Program
加拿大健康研究院 - 科学商业项目
- 批准号:
228226 - 财政年份:2011
- 资助金额:
$ 205.38万 - 项目类别:
Studentship Programs
Canadian Institutes of Health Research Science to Business 2010-2011 Fellowship Rotman School of Management , University of Toronto MBA Program
加拿大健康研究院科学商业2010-2011年奖学金 多伦多大学罗特曼管理学院MBA课程
- 批准号:
205281 - 财政年份:2010
- 资助金额:
$ 205.38万 - 项目类别:
Studentship Programs
Supporting Young Investigators Summer Research Institutes of the Consortium for the Science of Socio-Technical Systems
支持年轻研究者暑期社会技术系统科学联盟研究所
- 批准号:
0955449 - 财政年份:2009
- 资助金额:
$ 205.38万 - 项目类别:
Standard Grant